TFR1 upregulation and FPN downregulation have been reported in various cancer cell lines (Gao et al., 2015; Torti and Torti, 2019); therefore, ferroptosis-related genetic biomarkers may be considered potential therapeutic biomarkers for cancer treatment. Here, TFRC is linked to cancer.